|
1.
|
|
18 p, 3.0 MB |
Species traits and geomorphic setting as drivers of global soil carbon stocks in seagrass meadows
/
Kennedy, Hilary (Bangor University. School of Ocean Sciences (UK)) ;
Pagès, Jordi (Universitat de Barcelona. Departament de Biologia Evolutiva, Ecologia i Ciències Ambientals) ;
Lagomasino, D. (East Carolina University) ;
Arias Ortiz, Ariane (University of California. Institute of Marine Sciences) ;
Colarusso, Phil (United States Environmental Protection Agency) ;
Fourqurean, James (Florida International University. Institute of Environment) ;
Githaiga, M. N. (University of Embu. Department of Biological Sciences (Kenya)) ;
Howard, J. L. (Florida International University. Institute of Environment) ;
Krause-Jensen, D. (Aarhus University. Department of Ecoscience) ;
Kuwae, Tomohiro (Port and Airport Research Institute (Japan)) ;
Lavery, Paul S (Edith Cowan University. Centre for Marine Ecosystems Research) ;
Macreadie, Peter I (Deakin University. School of Life and Environmental Sciences) ;
Marbà, Núria (Institut Mediterrani d'Estudis Avançats) ;
Masqué Barri, Pere (Universitat Autònoma de Barcelona. Institut de Ciència i Tecnologia Ambientals) ;
Mazarrasa, Inés (Centre d'Estudis Avançats de Blanes) ;
Miyajima, Toshihiro (The University of Tokyo. Atmosphere and Ocean Research Institute) ;
Serrano, Oscar (Centre d'Estudis Avançats de Blanes) ;
Duarte, Carlos M. (King Abdullah University of Science and Technology. Computational Bioscience Research Center) ;
Universitat Autònoma de Barcelona.
Departament de Física
Our knowledge of the factors that can influence the stock of organic carbon (OC) that is stored in the soil of seagrass meadows is evolving, and several causal effects have been used to explain the variation of stocks observed at local to national scales. [...]
2022 -  10.1029/2022GB007481
Global Biogeochemical Cycles, Vol. 36, Issue 10 (October 2022) , art. e2022GB007481
|
|
|
2.
|
|
10 p, 772.3 KB |
Outcome of hospitalization for COVID-19 in patients with interstitial lung disease an international multicenter study
/
Drake, T. M. (Centre for Medical Informatics. The Usher Institute. University of Edinburgh) ;
Docherty, A. B. (Centre for Medical Informatics. The Usher Institute. University of Edinburgh) ;
Harrison, E. M. (Centre for Medical Informatics. The Usher Institute. University of Edinburgh) ;
Quint, J. K. (National Heart and Lung Institute. Imperial College) ;
Adamali, H. (Academic Respiratory Unit. University of Bristol. Southmead Hospital) ;
Agnew, Sarah (Liverpool Interstitial Lung Disease Service. Aintree site. Liverpool University Hospitals NHS Foundation Trust) ;
Babu, S. (Queen Alexandra Hospital (Portsmouth, Regne Unit)) ;
Barber, C. M. (Northern General Hospital) ;
Barratt, S. (Academic Respiratory Unit. University of Bristol. Southmead Hospital) ;
Bendstrup, Elisabeth (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Bianchi, S. (Northern General Hospital) ;
Castillo, Diego (Institut d'Investigació Biomèdica Sant Pau) ;
Chaudhuri, N. (University of Manchester) ;
Chua, F. (Royal Brompton and Harefield NHS Foundation Trust) ;
Coker, R. (Hammersmith Hospital (Londres)) ;
Chang, W. (Nottingham University Hospitals NHS Trust (Regne Unit)) ;
Crawshaw, A. (Birmingham Interstitial Lung Disease Unit. Queen Elizabeth Hospital Birmingham. University Hospitals Birmingham NHS Foundation Trust) ;
Crowley, L. E. (University of Birmingham) ;
Dosanjh, D. (Birmingham Interstitial Lung Disease Unit. Queen Elizabeth Hospital Birmingham. University Hospitals Birmingham NHS Foundation Trust) ;
Fiddler, C. A. (Cambridge University Hospitals NHS Foundation Trust (Regne Unit)) ;
Forrest, I. A. (Department of Respiratory Medicine. Royal Victoria Infirmary. Newcastle upon Tyne Hospitals NHS Foundation Trust) ;
George, P. M. (Royal Brompton and Harefield NHS Foundation Trust) ;
Gibbons, M. A. (South West Peninsula ILD Network. Royal Devon & Exeter Foundation NHS Trust) ;
Groom, K. (Hammersmith Hospital (Londres)) ;
Haney, S. (Northumbria Specialist Emergency Care Hospital. Northumbria Healthcare NHS Foundation Trust) ;
Hart, S. P. (Respiratory Research Group. Hull York Medical School. Castle Hill Hospital) ;
Heiden, E. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Henry, M. (Cork University Hospital) ;
Ho, L. P. (Oxford Interstitial Lung Disease Service. Oxford University Hospitals NHS Foundation Trust) ;
Hoyles, R. K. (Oxford Interstitial Lung Disease Service. Oxford University Hospitals NHS Foundation Trust) ;
Hutchinson, J. (King's Mill Hospital) ;
Hurley, K. (Beaumont Hospital (Dublín, Irlanda)) ;
Jones, M. (National Institute for Health Research (NIHR). Southampton Biomedical Research Centre & Clinical and Experimental Sciences. University of Southampton) ;
Jones, S. (Action for Pulmonary Fibrosis. Stuart House) ;
Kokosi, M. (Guys and St. Thomas' NHS Trust) ;
Kreuter, M. (Center for Interstitial and Rare Lung Diseases. Pneumology. Thoraxklinik. University of Heidelberg. German Center for Lung Research) ;
MacKay, L. S. (Northumbria Specialist Emergency Care Hospital. Northumbria Healthcare NHS Foundation Trust) ;
Mahendran, S. (Kingston Hospital NHS Foundation Trust) ;
Margaritopoulos, G. (ILD Unit. Manchester University Hospital NHS Foundation Trust. Wythenshawe Hospital) ;
Molina Molina, Maria (Institut d'Investigació Biomèdica de Bellvitge) ;
Molyneaux, P. L. (National Heart and Lung Institute. Imperial College) ;
O'Brien, A. (University Hospital Limerick) ;
O'Reilly, K. (Department of Respiratory Medicine. Mater Misericordiae University Hospital) ;
Packham, A. (Birmingham Interstitial Lung Disease Unit. Queen Elizabeth Hospital Birmingham. University Hospitals Birmingham NHS Foundation Trust) ;
Parfrey, H. (Cambridge University Hospitals NHS Foundation Trust (Regne Unit)) ;
Poletti, V. (Department of Diseases of the Thorax. Morgagni Hospital) ;
Porter, J. C. (UCL Respiratory. University College London. ILD Service. University College London Hospitals NHS Foundation Trust) ;
Renzoni, E. (Royal Brompton and Harefield NHS Foundation Trust) ;
Rivera-Ortega, P. (ILD Unit. Manchester University Hospital NHS Foundation Trust. Wythenshawe Hospital) ;
Russell, A. M. (Imperial Healthcare NHS Trust. St. Mary's Hospital. The Bays) ;
Saini, G. (Nottingham University Hospitals NHS Trust (Regne Unit)) ;
Spencer, L. G. (Liverpool Interstitial Lung Disease Service. Aintree site. Liverpool University Hospitals NHS Foundation Trust) ;
Stella, G. M. (Laboratory of Biochemistry and Genetics. Pneumology Unit. Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo) ;
Stone, H. (University Hospital North Midlands NHS Trust. Royal Stoke University Hospital) ;
Sturney, S. (Royal United Hospitals Bath NHS Foundation Trust) ;
Thickett, D. (University of Birmingham) ;
Thillai, M. (Cambridge University Hospitals NHS Foundation Trust (Regne Unit)) ;
Wallis, T. (National Institute for Health Research (NIHR). Southampton Biomedical Research Centre & Clinical and Experimental Sciences. University of Southampton) ;
Ward, K. (National Heart and Lung Institute. Imperial College) ;
Wells, A. U. (Royal Brompton and Harefield NHS Foundation Trust) ;
West, A. (Guys and St. Thomas' NHS Trust) ;
Wickremasinghe, M. (Imperial Healthcare NHS Trust. St. Mary's Hospital. The Bays) ;
Woodhead, F. (Institute of Lung Health. Interstitial Lung Disease Unit. Glenfield Hospital) ;
Hearson, G. (NIHR Biomedical Research Centre. Respiratory Research Unit. University of Nottingham) ;
Howard, L. (NIHR Biomedical Research Centre. Respiratory Research Unit. University of Nottingham) ;
Baillie, John Kenneth (Intensive Care Unit. Royal Infirmary Edinburgh) ;
Openshaw, Peter (National Heart and Lung Institute. Imperial College) ;
Semple, M. G. (Respiratory Medicine. Alder Hey Children's Hospital) ;
Stewart, I. (NIHR Biomedical Research Centre. Respiratory Research Unit. University of Nottingham) ;
Jenkins, R. G. (NIHR Biomedical Research Centre. Respiratory Research Unit. University of Nottingham) ;
Universitat Autònoma de Barcelona
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung disease (ILD) has not been established. Objectives: To assess outcomes in patients with ILD hospitalized for COVID-19 versus those without ILD in a contemporaneous age-, sex-, and comorbidity-matched population. [...]
2020 - 10.1164/rccm.202007-2794OC
American Journal of Respiratory and Critical Care Medicine, Vol. 202 Núm. 12 (15 2020) , p. 1656-1665
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
